Online CME

Nearly one-third of individuals 65 and older suffer with excessive daytime sleepiness (EDS), a condition marked by persistent sleepiness and a tendency to fall asleep at inappropriate times.

Left untreated, EDS can increase the risk of falls, affect memory, lead to mood disorders and cognitive impairment, and exacerbate existing medical conditions. It can also significantly impact an individual’s quality of life. Thus, it is important that healthcare professionals who work in long-term care facilities and other geriatric settings become familiar with the symptoms of EDS and the underlying medications and medical and psychiatric conditions that cause it, as well as recommended treatments.

Caring for Long Term Care, Assisted Living and Home Care Patients with Excessive Sleepiness employs a multidisciplinary approach to provide physicians, nurses, pharmacists, and other long-term care and geriatric health professionals with the information they need to identify and treat EDS in their patients, regardless of the setting.

LEARNING OBJECTIVESActivity Button

After completing this activity, participants should be able to:

  • Use clinical case studies to identify individuals with excessive daytime sleepiness.
  • Describe the differentiating neurophysiology of EDS of various etiologies.
  • Demonstrate the ability to establish and maintain effective treatment strategies for patients with EDS
  • Identify optimal treatment outcomes for EDS using clinical case studies

FACULTY INFORMATION

Darrell Hulisz
Darrell Hulisz, PharmD
Associate Professor, Department of Family Medicine
Case Western Reserve University, School of Medical
Cleveland, OH

Associate Clinical Professor
Department of Pharmacy Practice
Ohio Northern University,
College of Pharmacy

TARGET AUDIENCE

 This self-paced course is designed for Pharmacists and Pharmacy technicians who work with elderly patients in long-term care facilities, assisted living, home care, or on an outpatient basis.

PHARMACIST ACCREDITATION STATEMENT

This program has been reviewed and approved for 2 contact hours (0.20 CEUs).  Approval of this course for pharmacists is under a co-sponsorship agreement between the Institute for Postgraduate Continuing Education (IPGCE) and Continuing Education Company, Inc.  IPGCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy eduction.  The ACP Universal Program Number 490-999-09-001-H01-P has been assigned to this home study program.  The program is available for credit from April 10, 2009 to Apil 12, 2012.


PHARMACY TECHNICIAN ACCREDITATION STATEMENT

This program has been reviewed and approved for 2 contact hours (0.20 CEUs).  Approval of this course for pharmacists is under a co-sponsorship agreement between the Institute for Postgraduate Continuing Education (IPGCE) and Continuing Education Company, Inc.  IPGCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy eduction.  The ACP Universal Program Number 490-999-09-001-H01-T has been assigned to this home study program.  The program is available for credit from April 10, 2009 to Apil 12, 2012.

 

DISCLOSURES

 

Continuing Education Company adheres to ACCME and ACPE essential areas and policies, including the Standards for Commercial Support regarding industry support of continuing medical education. In order to resolve any identified conflicts of interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosures of faculty and commercial relationships, as well as the discussion of unlabeled/investigational use of any drug, device, or procedure by the faculty, are discussed below.

Darrell Hulisz is a consultant for the Quigley Corporation.

Employees of Continuing Education Company, IPGCE, the accredited provider for this activity, and Hamilton Consulting, as well as their spouses/life partners have not had any financial relationships or affiliations with any commercial interests related to this CME activity. 

DISCLOSURE OF UNLABELED USE/INVESTIGATIONAL USE

Continuing Education Company advises the participant that the presentations in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices.

INSTRUCTIONS FOR CREDIT

When finished listening to all the content, complete the post test, credit application and evaluation found at the end of the activity. You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. You will have three opportunities to successfully complete the test.

FEE

There is no fee for this educational activity. 

COMMERCIAL SUPPORT

This program is supported by an independent educational grant from Cephalon, Inc. 

DISCLAIMER

The opinions expressed in this educational activity are those of the faculty and do not reflect the views of Continuing Education Company, Inc. and Hamilton Consulting. This educational activity may discuss off-label and/or investigational uses and dosages for therapeutic products/procedures that have not been approved by the United States Food and Drug Administration (FDA). Continuing Education Company, Inc. and Hamilton Consulting, LLC do not recommend the use of any product/procedure outside of the labeled indications. A qualified health care professional should be consulted before using any therapeutic product/procedure discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity. Please refer to the official prescribing information for each product/procedures for approved indication, contraindications, and warnings.

Copyright © 2009 Continuing education Company, Inc. All Rights Reserved. Permission for accreditation use granted to Continuing Education Company, Inc.

PRIVACY POLICY

Continuing Education Company, Inc. (CEC) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. CEC and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Continuing Education Company, Inc. and Hamilton Consulting maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information. 

Activity Button